Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.04.29
2019年度财务决算报告
2020.04.29
第四届监事会第二十四次聚会决议通告
2020.04.29
2019年度内部控制自我评价报告
2020.04.29
内部控制规则落实自查表
2020.04.29
2019年年度审计报告
2020.04.29
2019年度监事会事情报告
2020.04.29
2019年度控股股东及其他关联方资金占用情形专项说明
2020.04.29
关于深圳市多普乐实业生长有限公司业绩允许实现情形说明的鉴证报告(2019年度)
2020.04.29
关于公司前期会计过失更正的专项报告
2020.04.29
关于深圳市多普乐实业生长有限公司2019年度业绩允许完成情形的说明
第一页
上一页
31
32
33
34
35
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】